|
Phase 2 Study assessing AMG 162 in the treatment of women with low bone density Clinical Trials Info presented on Clinical Trials Search isn't intended to be a substitute for certified health advice, travels to or treatment by using a genuine physician. We are not physicians. Always consult your dr. on Phase 2 Study assessing AMG 162 in the treatment of women with low bone density conditions. Clinical Trials Search.org is a site committed to listing clinical research studies in human subjects. Phase 2 Study assessing AMG 162 in the treatment of women with low bone density Clinical research trials and Phase 2 Study assessing AMG 162 in the treatment of women with low bone density health trials occur in hundreds of cities throughout the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically assess the effectivity of new drugs. The propose of the studies / undertakings is to resolve certain human health questions. Clinical trials are a popular means for physicians, government agencies, and private sector companies to locate treatments for all sorts of conditions, including Phase 2 Study assessing AMG 162 in the treatment of women with low bone density. Phase 2 Study assessing AMG 162 in the treatment of women with low bone density Clinical Trials and other clinical trials permit volunteers to acquire medical treatment choices before they are available to the masses. Some times the test subjects obtain professional assistance for free, and every now and again they are compensated for their time. Sometimes there is a cost for a Phase 2 Study assessing AMG 162 in the treatment of women with low bone density clinical trial. Participants oftentimes recieve the most expert healthcare available for their Phase 2 Study assessing AMG 162 in the treatment of women with low bone density condition. Hazards are a reality, however, and can include extra or frequent physician visits, health risks (potentially life-endangering), and/or the treatment being uneffective. Trials are federally governed with rigorous guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "P" Clinical Trials Conditions > Phase 2 Study assessing AMG 162 in the treatment of women with low bone density  Phase 2 Study assessing AMG 162 in the treatment of women with low bone density
Phase 2 Study assessing AMG 162 in the treatment of women with low bone density
For Condition: Osteoporosis,Osteopenia
Status: No longer recruiting
Sponsor(s): Amgen ,
Synopsis: Clinical research study of a novel protein, AMG 162, which has been shown in animal studies to regulate bone metabolism by inhibiting the cells that break down bone. This study will evaluate the effect of AMG 162 on bone mineral density in post menopausal women who have low bone mineral density.
Details:
Eligibility:
Study Type: Interventional, Treatment
Minimum Age/Maximum Age: 18 Years/85 Years
Genders: Female
Protocol Entry Criteria: Low bone mineral density, ambulatory, general good health, not currently receiving medication that affects bone metabolism
Total Enrollment:
Location and Contact Information:
Research Site
Palm Springs, Florida,
United States
Research Site
San Diego, California,
United States
Research Site
Ocala, Florida,
United States
Research Site
Beverly Hills, California,
United States
Research Site
Phoenix, Arizona,
United States
Research Site
Orland Park, Illinois,
United States
Research Site
Colorado Springs, Colorado,
United States
Research Site
Daytona, Florida,
United States
Research Site
Lake Worth, Florida,
United States
Research Site
Laguna Woods, California,
United States
Research Site
San Antonio, Texas,
United States
Research Site
Los Angeles, California,
United States
Research Site
Palo Alto, California,
United States
Research Site
Dallas, Texas,
United States
Research Site
Indianapolis, Indiana,
United States
Research Site
Rancho Cucamonga, California,
United States
Research Site
Duncansville, Pennsylvania,
United States
Research Site
Venice, Florida,
United States
Research Site
Lakewood, Colorado,
United States
Research Site
Cincinnati, Ohio,
United States
Research Site
Bethesda, Maryland,
United States
Research Site
Kalamazoo, Michigan,
United States
Research Site
Lakewood, Washington,
United States
Research Site
Elmsford, New York,
United States
Research Site
Lenexa, Kansas,
United States
Research Site
Walnut Creek, California,
United States
Research Site
Leesburg, Florida,
United States
Research Site
Wyomissing, Pennsylvania,
United States
Research Site
Seattle, Washington,
United States
Research Site
San Francisco, California,
United States
Additional Information:
Study ID Numbers: 20010223;
Study Start Date:
Record last reviewed: January 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00043186
Other Osteopenia Studies:
1. Goserelin in Preventing Ovarian Failure in Women Receiving Adjuvant Chemotherapy for Breast Cancer
2. Efficacy and Safety of 100 mg and 150 mg Monthly Oral Ibandronate in Women with Postmenopausal Osteoporosis
3. Randomized Study of Alendronate in Adult Patients With Cystic Fibrosis Related Osteoporosis
4. Bone Mineral Density in Women with Major Depression
5. The BONES Project: Building Healthy Bones in Children
Related Studies:
Other Osteopenia Clinical Trials
Other California Clinical Trials
Other San Diego Clinical Trials
Phase 2 Study assessing AMG 162 in the treatment of women with low bone density
|
|
|
|
|
|
|
|
